Atlas Trials

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Clinical trial NCT07714577 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07714577
Sponsor
Tianjin First Central Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HPV16/18 Positive
Start date
2026-07-30
Primary completion
2030-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.